Arcus Biosciences, Inc.
RCUS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $247M | $258M | −4.3% |
| Operating income | −$386M | −$330M | −17.0% |
| Net income | −$353M | −$283M | −24.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $9.00M | $26.0M | −65.4% |
| Operating income | −$131M | −$142M | +7.7% |
| Net income | −$128M | −$135M | +5.2% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Arcus's revenue in FY2025?
- $247M in FY2025 (Fiscal year ended Dec 31, 2025), −4.3% vs $258M a year earlier, per its 10-K filed Feb 2026.
- Was Arcus profitable in FY2025?
- No: net income was −$353M and operating income −$386M in FY2025.
- What was Arcus's revenue in Q3 2026?
- $9.00M (−65.4% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.